STRATENITY · INDUSTRY ONE-PAGER · DEEP TECH
CONFIDENTIAL · JULY 2026
Deep Tech
Industry Outlook · US Market · 2026
Scan Type
Industry Snapshot
Structured, repeatable read of sector economics, signals, gaps, and engagement pathways.
Global VC
~$60B invested
~20% of all venture funding
Deep-tech investment ~2x over five years
STRATENITY READ · Deep tech is where frontier hard science becomes commercial infrastructure, and it is the most capital-intensive, longest-horizon corner of the venture economy. The core tension is durable: breakthroughs in quantum, advanced semiconductors, robotics, advanced materials, and fusion carry defensible IP and strategic value, yet they must cross a punishing "valley of death" between a working demonstration and a manufacturable, financeable product. Government and strategic capital (CHIPS Act, DARPA, national labs) can bridge early risk, but talent is scarce at the PhD level and dual-use exposure invites export controls. Ventures that win will treat commercialization, capital strategy, and manufacturing scale-up as one connected operating problem rather than isolated science, fundraising, and factory decisions.
$60B
Deep-Tech VC / Yr
Roughly a fifth of global venture capital now flows to deep tech.
7-10yr
R&D-to-Revenue
Long science-to-scale cycles versus 1-3 years for software.
$52B
CHIPS Act Funding
Federal incentives for domestic semiconductor R&D and fabs.
~70%
Hardware-Centric
Most deep-tech ventures build physical product, not pure software.
~2x
5-Yr Funding Growth
Deep-tech investment has roughly doubled over five years.
~40%
Corporate / Strategic
Share of rounds with strategic or government-linked capital.
01 Industry Profile
Sub-sectorsQuantum, Semiconductors, Robotics, Materials, Fusion, AI Infra
Global VC~$60B / yr into deep tech (2026)
ForecastSustained double-digit funding growth
Capital mixVC, corporate strategic, government / grants
TalentPhD-scarce; concentrated near labs and universities
02 Cycle Drivers
1
Government and strategic capital. CHIPS Act, DARPA, and national labs de-risk early frontier R&D and domestic manufacturing.
2
Science-to-commercialization gap. The valley of death between a lab demonstration and a manufacturable product defines survival.
3
PhD-level talent scarcity. Frontier ventures compete for a thin pool of specialized scientists and engineers.
4
Dual-use and export controls. Quantum, chips, and materials carry security exposure that shapes markets and compliance.
Major Players
NVIDIA
TSMC
IBM / IonQ
Boston Dynamics
Commonwealth Fusion
National Labs
Lux / DCVC
03 Industry Signals
Government and strategic capital surge
CHIPS Act, DARPA, and national-lab programs anchor domestic frontier R&D, pulling private capital toward hard science.
Science-to-commercialization valley of death
Many ventures stall between a working demonstration and a financeable, manufacturable product; scale-up risk dominates.
PhD talent scarcity
Specialized scientific talent is thin and concentrated; recruiting and retention are strategic, not HR-only, issues.
Dual-use and export controls
ITAR, EAR, and CHIPS-linked rules govern chips, quantum, and materials, reshaping addressable markets and partnerships.
Long-horizon, patient capital
Investors accept 7-to-10-year cycles, favoring defensible IP and deep moats over near-term revenue traction.
05 Sector Recommendations
NowBuild a commercialization roadmap that stages the crossing from lab demonstration to first manufacturable, revenue-bearing product.
30-60dAssemble a blended capital and grant strategy across VC, strategic partners, and CHIPS or DARPA non-dilutive funding.
60-90dStand up IP and dual-use compliance and a manufacturing scale-up plan before committing to first-customer deployment.
04 Industry Gap Analysis
G1
Commercialization and scale-up. Working demonstrations lack a staged path to a manufacturable, financeable product across the valley of death.
G2
Capital intensity and financing. Long R&D cycles need blended VC, strategic, and non-dilutive capital that many teams cannot yet assemble.
G3
PhD-level talent. Scarce specialized scientists and engineers constrain velocity; recruiting pipelines are under-built.
G4
IP moat and dual-use compliance. Patent depth is uneven and export-control exposure (ITAR, EAR) is inconsistently governed.
G5
Manufacturing and supply. Pilot-line to volume manufacturing and fragile deep-tech supply chains block reliable scale.
G6
Go-to-market and first customers. Frontier products lack proven buyers; first-customer and reference-account motions are immature.
Stratenity Signal Profile
Regulatory
Export / CHIPS / Dual-Use
Primary Domain
Commercialization & Capital-Intensive Scale-Up
Recommended Module
VelorStrategy · Execution Workspace
Suggested assets: Commercialization Roadmap · Capital & Grant Strategy · Dual-Use Compliance Kit
Data confidence: High (public sources)
Last reviewed: July 2026
06 Strategic Engagement Opportunities
| Engagement Track | Strategic Thesis | $ Range |
|---|
| Commercialization Roadmap | Stage the crossing from lab demonstration to manufacturable, revenue-bearing product across the valley of death. | $250K-$1.5M |
| Capital & Grant Strategy | Assemble blended VC, strategic, and non-dilutive CHIPS or DARPA funding matched to long R&D horizons. | $180K-$900K |
| PhD Talent & Team Build | Design recruiting and retention for scarce scientific talent near labs, universities, and research hubs. | $150K-$800K |
| IP & Dual-Use Compliance | Deepen patent moats and stand up ITAR, EAR, and export-control governance for dual-use technology. | $160K-$850K |
| Manufacturing Scale-Up | Build the pilot-line to volume manufacturing path and de-risk fragile deep-tech supply chains. | $300K-$2M |
| GTM / First-Customer Motion | Design first-customer, reference-account, and pricing motions for unproven frontier products. | $120K-$700K |
| Partnerships / National-Lab | Structure national-lab, strategic, and corporate partnerships to access capital, facilities, and channels. | $220K-$1.2M |
Total Addressable Engagement Value
$1.4M - $7.95M
across a 12-24 month engagement horizon
·Industry Outlook
Repeatable, versioned sector read covering economics, signals, gaps, and cycle drivers.
·Competitor Scans
Structured profiles of frontier ventures, incumbents, and deep-tech investors with positioning and moves.
·Market Entry Scan
Entry, expansion, and partnership analysis scoped to a target segment or geography.
·Bespoke / Regulatory
Advisory on export controls, dual-use, and CHIPS exposure plus governed AI and manufacturing paths.
We can build this same industry view on any sector your clients pursue.
One repeatable, governed format across every market you advise, from healthcare to fintech to energy.
REQUEST A SECTOR SCAN